-
Invasive aspergillosis among neutropenic patients could be reliably diagnosed using a commercial test Fungitell to detect the cell wall component (1->3)-ß-D-glucan of certain fungi, including Aspergillus. However, diagnosis was more accurate when both (1->3)-ß-D-glucan and galactomannan were detected.
-
A 46-year-old male presented to a San Jose, California, hospital emergency department with with bilateral diplopia dysphagia, dysphonia, and weakness of his proximal arms. He had been seen in several other medical care facilities over the previous days without diagnosis. The patient regularly self-injected with black tar heroin and had been doing so for 8 years.
-
New research indicates that lower bone density appears to recover in adolescent females once they stop using the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo Provera, Pfizer, New York City).
-
The Food and Drug Administration (FDA) has issued an alert concerning use of unapproved home-use diagnostic test kits marketed over the Internet.
-
New research indicates that use of the contraceptive patch results in greater cost savings and reductions in pregnancy, compared with combination oral contraceptives, due to improved compliance by patients.
-
Results of new research suggest that being overweight may increase womens risk of becoming pregnant while using oral contraceptives. How do these findings play into contraceptive counseling for clinicians?
-
Researchers are taking a hard look at the forgotten half of the transmission equation of human papillomavirus (HPV). Investigators are recruiting 3,000 healthy men, ages 18 to 44, in the United States, Mexico, and Brazil to determine mens roles in spreading the sexually transmitted organism, which is linked to cervical cancer in women.
-
Put your diagnostic skills into high gear to spot lymphogranuloma venereum (LGV), a sexually transmitted disease caused by a type
of Chlamydia trachomatis.
-
What is your approach when checking for copper allergy in women considering use of the Copper T380A (ParaGard, FEI, Addison, TX)? What are your directions on use of the levonorgestrel-only EC, Plan B (Barr Pharmaceuticals, Pomona, NY)?
-
In late September 2004, the Department of Health and Human Services announced a new round of national and regional grantees for the infant adoption awareness-training program. Given the dubious track record of this program during its first three years of operation, many family planning providers are hopeful that this will bring much-needed changes to the national training curriculum.
